Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trialAdrian F. Hernandez, Lauren B. Cooper, Shaun G. Goodman et al.|The Lancet|2018Cited by 1.8k
Evaluation and Treatment of Patients With Lower Extremity Peripheral Artery DiseaseManesh R. Patel, Mitchell W. Krucoff, Michael S. Conte et al.|Journal of the American College of Cardiology|2015Cited by 374
Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trialA. Michael Lincoff, John H. Alexander, Roxana Mehran et al.|The Lancet|2015Cited by 151
A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trialThomas J. Povsic, John H. Alexander, John P. Vavalle et al.|European Heart Journal|2012Cited by 108
Nucleic acid aptamers as antithrombotic agents: Opportunities in extracellular therapeuticsThomas J. Povsic, Richard Becker, Mauricio G. Cohen et al.|Thrombosis and Haemostasis|2010Cited by 48